Welgene Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Welgene Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 17.3 TWD Market Closed

Market Cap: NT$403.1m

W	Welgene Biotech Co Ltd TPEX:6661	TW
T	Telefonica SA XMUN:TNE5	ES
	Drax Group PLC LSE:DRX	UK
	Blockmate Ventures Inc OTC:MATEF	UK
	Eldorado Gold Corp TSX:ELD	CA
E	Eventbrite Inc SWB:EB4	US
	Cizzle Biotechnology Holdings PLC LSE:CIZ	UK
A	Acacia Research Corp F:AZG2	US

Profitability Summary

Welgene Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

42%

Sustainable 3Y Average Gross Margin

42%

Declining Gross Margin

43% > 42%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-1% > -1%

Negative Net Margin

Negative 3Y Average Net Margin

Net Margin is Increasing

-1% > 0%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

-15% > -26%

Negative ROE

-1%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1%

ROIC is Increasing

-3% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

42%

Sustainable 3Y Average Gross Margin

42%

Declining Gross Margin

43% > 42%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-1% > -1%